0000899243-21-024531.txt : 20210617
0000899243-21-024531.hdr.sgml : 20210617
20210617195518
ACCESSION NUMBER: 0000899243-21-024531
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Jodie Pope
CENTRAL INDEX KEY: 0001618247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 211026637
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-15
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001618247
Morrison Jodie Pope
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
1
0
0
0
Stock Option (right to buy)
1.29
2021-06-15
4
A
0
96000
0.00
A
2031-06-14
Common Stock
96000
96000
D
This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders.
/s/ Rick Wanstall, attorney-in-fact for Jodie Pope Morrison
2021-06-17